Infinium Global Research

Global Cardiac Biomarkers Market: Latest Global Insights, Growth Factors, Challenges and Industry Trends 2019-2025

A recent report published by Infinium Global Research on cardiac biomarkers market provides an in-depth analysis of segments and sub-segments in the global as well as regional cardiac biomarkers industry


Pune, India -- (SBWIRE) -- 11/29/2019 -- The Infinium Global Research analyzes the "Cardiac Biomarkers Market (Type - Myocardial Muscle Creatine Kinase (CK-MB), Troponins (T and I), Myoglobin, Brain Natriuretic Peptide (BNPs) or NT-proBNP, Ischemia Modified Albumin (IMA), and Other Types; Location of Testing - Point of Care Testing, and Laboratory Testing; Applications - Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Other Applications): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025." The global nutritional analysis market is projected to grow at a CAGR of 10.5% over the forecast period of 2019-2025.

For More Details Get FREE Sample Pages of this Premium Global Report@

The Rise in Awareness Regarding Early Diagnosis of Various Cardiovascular Diseases Boost Growth for Cardiac Biomarkers Market

The rising prevalence of cardiovascular diseases and growing population across the globe are primary driving factors for the cardiac biomarkers market. Further, growing funding from public or private organizations for research on cardiac biomarkers is fueling the growth of the market. Development and advancement in cardiac biomarkers are expected to drive the growth of the market in the forecasted period. On the other hand, technical problems related to sample collection and storage are restraining the growth of the cardiac biomarkers market. Moreover, rising awareness among patients and healthcare providers about the importance of early diagnosis of various CVDs is anticipated to provide growth opportunities to the market players.

Troponins (T and I) Segment Holds Premium Share in the Global Cardiac Biomarkers Market

The global cardiac biomarkers market is segmented based on type, location of testing, applications. On the basis of the type, the market is segmented into myocardial muscle creatine kinase (CK-MB), troponins (T and I), myoglobin, brain natriuretic peptide (BNP) or NT-proBNP, ischemia modified albumin (IMA), and other types. The troponins (T and I) segment holds a large market share of the global cardiac biomarkers market.

Based on the location of testing, the sub-markets include point of care testing and laboratory testing. By application, the market is categorized into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis, and other applications. The myocardial infarction (MI) segment holds the highest market share in the global cardiac biomarker market due to the highest prevalence rate among cardiovascular diseases (CVDs).

Ask Discount for the Latest Research Report @  

The Rise in Number of People Suffering From Cardiovascular Disease in North America Prevail the Market for the Region

Among the regions, North America holds the largest market share of the global cardiac biomarkers market followed by Asia-Pacific. The rising patient population suffering from cardiovascular diseases such as angina pectoris, myocardial infarction, etc. is driving the growth of the market in the North America region. The modernization, increasing disposable incomes and growing affordability for the advanced cardiac treatments driving the growth of the market in Asia-Pacific.

Cardiac Biomarkers Market: Competitive Analysis

Some of the industry participants of the global cardiac biomarkers market are Beckman Coulter, Inc., Roche Diagnostics Limited, Abbott Laboratories, bioMérieux SA, Johnson and Johnson, Olympus Corporation, Siemens Healthcare GmbH, Tosoh Corporation, F. Hoffmann-La Roche Ltd., and PerkinElmer Inc. among the others.

Browse Complete Global Report and Detailed TOC:

Reasons to Buy this Report:

=> Comprehensive analysis of global as well as regional markets of the cardiac biomarkers.

=> Complete coverage of all the product type and application segments to analyze the trends, developments, and forecast of market size up to 2025.

=> Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.  

=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.